Skip to main content
. 2011 May 25;286(28):24666–24673. doi: 10.1074/jbc.M111.236273

FIGURE 3.

FIGURE 3.

Characterization of caspases in 24S-OHC-treated SH-SY5Y cells. The cells were treated with 24S-OHC or STS for the indicated times, and the cell samples were then subjected to the enzyme assay (A) using DEVD-AMC (panel 1) or LEHD-AMC (panel 2) as a substrate and Western blot analysis (B) using an antibody against caspase-3 (panel 1) or caspase-9 (panel 2). **, p < 0.01, when compared with vehicle control (without 24S-OHC).

HHS Vulnerability Disclosure